Table 1.
Total | Pre-COVID-19 | Post-COVID-19 | p-value | |
---|---|---|---|---|
N | 50,158 | 33,073 | 17,085 | |
Period | 2015–2021 | 2015–2019 | 2020–2021 | |
Age (year) | 51.88 ± 17.09 | 51.54 ± 16.90 | 52.53 ± 17.42 | < 0.001* |
Sex (M:F) | 22,284:27,874 | 14,714:18,359 | 7570:9515 | 0.704 |
Cataract | 7270 (16.0%) | 4477 (15.0%) | 2793 (18.1%) | < 0.001* |
Glaucoma | 921 (2.0%) | 599 (2.0%) | 322 (2.1%) | 0.419 |
AMD | 439 (1.0%) | 236 (0.8%) | 203 (1.3%) | < 0.001* |
AMD age-related macular degeneration. *p <0.05